Search

Your search keyword '"Yoshida, Shinichiro"' showing total 613 results

Search Constraints

Start Over You searched for: Author "Yoshida, Shinichiro" Remove constraint Author: "Yoshida, Shinichiro"
613 results on '"Yoshida, Shinichiro"'

Search Results

51. Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: Study by the Nagasaki CML Study Group

52. Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki

54. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma ( JCOG1105 )

56. Oral histone deacetylase inhibitor tucidinostat ( HBI ‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results

57. Newborn screening for Gaucher disease in Japan

58. Successful use of an LVIS device to treat unruptured distal aneurysm of the superior cerebellar artery at a vascular bifurcation

59. Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group

60. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

66. Secreted Frizzled-Related Protein 1 Promotes Odontoblastic Differentiation and Reparative Dentin Formation in Dental Pulp Cells

68. The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience

69. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study

72. Tissue Accumulation of Neutrophil Extracellular Traps Mediates Muscle Hyperalgesia in a Mouse Model

73. Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group

76. Current Status of Newborn Screening for Pompe Disease in Japan

77. Additional file 2 of Current status of newborn screening for Pompe disease in Japan

78. Additional file 1 of Current status of newborn screening for Pompe disease in Japan

79. Additional file 3 of Current status of newborn screening for Pompe disease in Japan

81. Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts

83. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)

84. Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group

85. Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

87. Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in Nagasaki prefecture, Japan

89. Additional file 1 of Fabry disease screening in high-risk populations in Japan: a nationwide study

91. Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: Study by the Nagasaki CML Study Group

95. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan

97. Health Inequality Among Older Adults with Percutaneous Coronary Intervention and Universal Health Coverage in Japan.

99. No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki

100. Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients

Catalog

Books, media, physical & digital resources